PARIS — Long-term 7-year follow-up data from the Portal extension trial support the port delivery system as an effective strategy to maintain long-term visual outcomes with reduced treatment burden.At the Euretina congress, Arshad M. Khanani, MD, MA, F…
New Blue Zones Certification focuses on wellness, longevity
DALLAS — Blue Zones and the American College of Lifestyle Medicine developed a certification process designed to equip physicians with tools to address chronic disease using evidence-based lifestyle medicine interventions.The course combines the Americ…
Stevens-Johnson syndrome: Ocular surface changes and management
Stevens-Johnson syndrome is a mucocutaneous immune-mediated hypersensitivity reaction. It is often triggered by drugs or infections. It presents as a skin and mucous membrane drug hypersensitivity reaction with variable severity.Stevens-Johnson syndrom…
Man presents with darkening vision, vesicular lesions
A 55-year-old white man with a medical history of well-controlled type 2 diabetes, rheumatoid arthritis and fibromyalgia presented with progressively worsening, painless decline in vision of both eyes.His ocular history was notable for keratoconus in b…
Childhood Sjögren Disease Tied to Distinct Disease Patterns
Patients with childhood-onset Sjögren disease show distinct trajectories for disease activity and symptoms, with a notable proportion having an increased risk for lymphoma and early glandular damage. Medscape Medical News
Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today announced that it is well along in the multi-step and time-consuming process that is required to call a Special Meeting of Shareholders (the “Speci…